Lilly del Caribe, Inc – FDA 483, Jul 23, 2013
Lilly del Caribe, Inc. in Carolina, PR, was inspected and received a Form 483 with four observations. The inspection revealed significant issues including inadequate investigations into consumer complaints about capsule defects, failure to submit required field alert reports, and a quality control unit that did not properly manage nonconforming materials. Additionally, the facility suffered from recurring microbial contamination in manufacturing areas due to environmental control deficiencies.
ID · 0c58a251-c690-4739-9d0d-2098e0f0ec8e
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.